DailyIQ
Last updatedjust now

WAT·Waters Corporation

$439.13
+9.96 (+2.32%)
High
$441.88
Open
$430.88
Market Cap
42.45B
52W High
$454.54
Low
$429.89
P. Close
$439.13
P/E
255.53
52W Low
$282.77
Fwd P/E
26.68
DailyIQ Est.
$471.79
Inst. Ownership
42.3%
Short Interest
3.44%
Days to Cover
4.4
NewEarnings release, scored · filed Aug 4, 2026Guidance raised · tone +9.7 vs prior release · 38 lines scoredSee the breakdown
Technical Score (1D)
50
NEUTRAL
News Sentiment
80
BULLISH
On Oct 13, Waters announced the launch of its AI Link platform, a new tool designed to streamline liquid chromatography‑mass spectrometry (LC‑MS) workflows from research to commercial release. The platform integrates machine‑learning models to automate data acquisition and analysis, reducing manual effort and accelerating product development. By automating routine tasks, the company said it could improve throughput and consistency across laboratories. The launch was positioned as a move to capture a larger share of the growing AI‑enabled analytical market. The announcement highlighted the platform’s potential to speed time‑to‑market for analytical solutions.
LOW TARGET
$349 -20.5%
2 analysts
MEAN TARGET
$458 +4.3%
18 analysts
HIGH TARGET
$530 +20.7%
13 analysts
PRICE RANGE
$349.00 - $530.00
SB / B / H / S / SS
9/11/11/1/1
DAILYIQ EST.
$471.79 (+7.4%)
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NYQ
Country
United States
Website
Symbol
WAT
Description
Waters Corporation is a global provider of analytical workflow solutions, primarily operating in the Americas, Europe, and Asia. The company's core business centers around the design, manufacture, and servicing of high-performance liquid chromatography and mass spectrometry systems, along with related consumables and services. Waters' technology is utilized across a wide range of applications, including drug discovery, clinical trials, and environmental testing, serving diverse customer segments such as pharmaceutical companies, research institutions, and government agencies. Furthermore, Waters offers thermal analysis instruments that assess the properties of materials used in a variety of industries. Founded in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
Bought (1Y)
0 shares
$0
Sold (1Y)
4,054 shares
$1.6M
Jiang Wei-
Award/Grant57.41 shares2026-09-30
Knight Heather-
Award/Grant57.41 shares2026-09-30
KUEBLER CHRISTOPHER A-
Option Exercise3,626 shares2026-08-06
KUEBLER CHRISTOPHER A-
Sell3,626 shares2026-08-06
KUEBLER CHRISTOPHER A-
Option Exercise3,626 shares2026-08-06
76/ 100
Bullish
Overall: Bullish
✓Revenue growing year over year
✓Positive net margin
✓Positive operating cash flow
Gross Margin
59.3%
Net Margin
20.3%
Revenue CAGR
4.3%
Current Ratio
1.73x
Debt / Equity
0.37x
Return on Equity
25.1%
Earnings Summary
Waters Corporation, a global provider of analytical workflow solutions, designs and manufactures high‑performance liquid chromatography and mass spectrometry systems used in drug discovery, clinical trials, and environmental testing, operating across the Americas, Europe, and Asia. The company’s diagnostics and research focus places it within the broader healthcare sector, where precision instrumentation drives scientific innovation. In the most recent quarters, Waters reported Q4 2025 EPS of $4.53 versus an estimate of $2.47, a substantial beat, and revenue of $932.36 M against a $711.61 M estimate, marking a 31% revenue increase. Q1 2026 EPS rose to $2.70 from $2.25, and revenue reached $1.267 B, up 4.2% from the prior quarter and 12% from the same period a year earlier. The company has consistently outperformed earnings estimates in the last four quarters, with EPS beats in each period and revenue growth accelerating from 12% YoY in Q1 2026 to 31% in Q4 2025. Historically, Waters has shown a steady YoY revenue expansion, with EPS growth often exceeding analyst expectations, indicating robust profitability despite seasonal revenue fluctuations. Recent analyst activity underscores this trend: Baird, Evercore ISI, and Barclays have all raised price targets to $480–$500, citing confidence in the company’s earnings trajectory and operational improvements.

EPS

EstBeatMiss
$2.03$2.74$3.44$4.15$4.86Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$4.00 - -
Q2'26$3.99$3.05-23.6%
Q1'26$2.36$2.70+14.4%
Q4'25$2.47$4.53+83.1%
Q3'25$3.22$3.40+5.5%
Q2'25$2.94$2.95+0.3%

Revenue

EstBeatMiss
$553M$897M$1.2B$1.6B$1.9BQ2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$1.8B - -
Q2'26$1.6B$1.6B+0.4%
Q1'26$1.2B$1.3B+4.3%
Q4'25$712M$932M+31.0%
Q3'25 - $800M -
Q2'25 - $771M -

Market Data

WAT Stock Snapshot

NEUTRAL50/100
$439.13+$9.96 (2.3%)
Market cap
42.45B
P/E ratio
255.5
Day range
$429.89 – $441.88
News sentiment
80/100 · Bullish
Analyst target
$458.22 (+4.3%)
Consensus
Buy · 33 analysts
52-week range+55.3% off low · -3.4% from high
$282.77$454.54
Price $439.13 DailyIQ Est. $471.79

Momentum has flattened on WAT, leaving the next move dependent on news rather than the chart. Sector peers are worth watching - large caps in Healthcare tend to move together on rotation.

Reverse DCF

What growth is priced into WAT?

RICH

At today's price, Waters Corporation needs to grow free cash flow about 33.9% a year for the next 10 years to justify its valuation at a 9.73% cost of capital. Over its actual history it has compounded free cash flow at 3.0% a year, so the market is asking for 30.9 percentage points above its own delivered rate. On that basis WAT looks priced above what its own growth record supports.

Implied FCF growth
33.9%
Historical FCF CAGR
3.0%
Growth gap
+30.9 pts
Verdict
RICH
Discount rate (WACC)
9.73%
Beta
0.91

Behaviour On Record

What WAT's own history says about today's numbers

Realized volatility (21d)
26.4% 60th pct
Below its peak
-3.2%
vs 200-day average
+17.6%
Up days (1y)
50%

Waters Corporation is currently running 26.4% annualised volatility over the last 21 sessions. Measured against WAT's own 13 years of daily returns rather than a market-wide average, that is the 60th percentile — close to its own typical level, against a typical reading of 23.9%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

WAT is trading -3.2% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -21.5%, and the deepest was -33.5% in 2020. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.

Price sits +17.6% from its 200-day moving average. Against every other day in its history, that gap ranks at the 87th percentile — a wider gap than this stock usually carries. Over the past year WAT closed higher on 50% of sessions, and it is currently 2 sessions into a falling streak.

On October specifically: over 13 years of records, WAT finished the month higher 7 of 13 times, with a median return of +3.3% and an average of +1.5%. Its strongest month historically has been July at +3.7% on average, its weakest February at -2.3%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: WAT has opened more than 2% away from the prior close in 103 of 3,267 sessions (3.2% of the time), with the largest gaps running +11.7% and -46.9%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

Across the last 3 dated reports on file, WAT moved an average of 0.6% in the session after earnings, closing higher 3 of those 3 times, with a median move of +0.7% and a largest of +1.0%.

All figures computed from 3,268 daily closes between 2013-10-15 and 2026-10-13, split-adjusted, recomputed daily. Percentiles are against WAT's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of WAT's sector?

Waters Corporation sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading).

Sector rank
#2 of 12
Sector state
Leading
Sector rotation score
91

Options Market

What is the options market pricing for WAT?

CallsPuts

For Waters Corporation's nearest expiry (2026-10-16, 2 days out), open interest is call-heavy, a bullish tilt (put/call ratio of 0.21), with at-the-money implied volatility around 50.9%. The options market is pricing roughly a ±4.3% move by that expiry — a range of about $417.34–$454.98.

Put/call ratio (2026-10-16)
0.21
ATM implied volatility
50.9%
Total open interest
368
Expected move by 2026-10-16
±4.3% ($417.34–$454.98)

Analyst Rating Changes

Are analysts turning bullish or bearish on WAT?

TD Cowen most recently reiterated its rating on Waters Corporation to Buy on Oct 13, 2026 with a price target of $515 (from $475). Over the last 90 days, coverage has run 3 upgrades against 0 downgrades, a net bullish lean.

Latest action
TD Cowen — Buy
90-day upgrades
3
90-day downgrades
0
Net rating momentum
+3
DateFirmActionRatingPrice target
Oct 13, 2026TD CowenMaintainedBuy$475 → $515
Oct 7, 2026BarclaysMaintainedOverweight$460 → $500
Oct 1, 2026GuggenheimMaintainedBuy$440 → $490
Sep 21, 2026Goldman SachsMaintainedBuy$465 → $515
Sep 9, 2026UBSUpgradeNeutral → Buy$375 → $490
Aug 27, 2026Piper SandlerUpgradeNeutral → Overweight$400 → $480
Aug 10, 2026CitigroupMaintainedBuy$425 → $470
Aug 5, 2026TD CowenUpgradeHold → Buy$408 → $475
Aug 5, 2026RBC CapitalMaintainedOutperform$435 → $475
Aug 5, 2026Evercore ISI GroupMaintainedOutperform$410 → $420
Aug 5, 2026Wells FargoMaintainedEqual-Weight$370 → $400
Aug 5, 2026BarclaysMaintainedOverweight$425 → $460

Earnings Release, Scored

What did Waters Corporation's latest earnings release say?

Filed Aug 4, 2026 · SEC Form 8-K, Exhibit 99

Guidance raised
Tone83.0/ 100+9.7 vs prior release
Hedging words0.23per 100 words-0.11 vs prior release
Tone, last 2 releasesScale 50–88

Most important lines

  1. 1

    The Company is raising all components of its full-year 2026 guidance, given better-than-expected results and broad strengthening in end-market conditions.

    Guidance raisedNew this quarter
  2. 2

    Dr. Batra continued, “With momentum building across our portfolio, end markets, and synergies, we are raising every component of our full-year 2026 guidance.

    Guidance raisedNew this quarter
  3. 3

    The Company is raising its acquired business revenue expectation and now expects full-year 2026 acquired business reported revenue of approximately $3.045 billion on an owned-period basis.

    Guidance raised

Peers & ETF holders

WAT peers & ETF holders

News Sentiment Analysis

Sentiment gathered from recent headlines

80/100
Strong NegativeNeutralStrong Positive
BULLISH

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles
What did this article say?
Waters Corporation announced the launch of its AI Link software, integrating Anthropic’s Model Context Protocol into its informatics platform. The new capability enables AI‑enabled liquid chromatography‑mass spectrometry workflows to move from research to commercial release. By joining Anthropic’s Model Hardware Standard research program, Waters positions itself at the forefront of AI‑driven analytical chemistry. The announcement signals a strategic push to enhance data analysis speed and accuracy for its customers.
What did this article say?
Baird lifted its price target for Waters (WAT) to $495 from $456, reflecting a more optimistic outlook. The brokerage maintains an overweight rating and cites an average target of $461.59 from FactSet‑polled analysts. The upgrade signals confidence in Waters’ growth prospects and earnings trajectory. This adjustment may influence investor sentiment and trading activity in the near term.
What did this article say?
Evercore ISI increased its price target for Waters (WAT) to $480 from $410, reflecting a bullish outlook on the company’s prospects. The upgrade aligns with the firm’s overweight rating and a mean target of $451.18 across analysts. The adjustment signals confidence in Waters’ growth trajectory and potential upside for investors.
What did this article say?
Barclays analyst Luke Sergott upgraded Waters (NYSE:WAT) to an Overweight rating and raised its price target from $460 to $500. The upgrade reflects confidence in the company’s growth prospects and earnings outlook. The new target suggests a potential upside for investors, indicating a positive market view of the firm’s future performance.
What did this article say?
Barclays increased its price target for Waters (WAT) to $500 from $460 while maintaining an overweight rating. The upgrade reflects confidence in the company’s growth prospects and recent operational improvements. Analysts noted that the new target aligns with a bullish view of the water infrastructure sector. The rating change signals a positive outlook for investors holding or considering WAT shares.
What did this article say?
Waters Corporation scheduled its third‑quarter 2026 earnings conference call for November 3, 2026, at 8:00 a.m. Eastern Time. The company will webcast the presentation on its Investor Relations website, with a replay available until December 1, 2026. The announcement provides investors with the date and logistics for the upcoming earnings release. No financial guidance or performance updates were disclosed in the notice.
What did this article say?
Guggenheim analyst Subbu Nambi upgraded Waters (NYSE:WAT) to a Buy rating and increased the price target from $440 to $490. The upgrade reflects confidence in the company’s growth prospects and earnings outlook. The higher target suggests a bullish view on future performance and potential upside for investors.
What did this article say?
Waters (NYSE:WAT) has outperformed the broader market over the past two decades, achieving an average annual return of 11.99% versus a 2.95% market gain. The company’s market capitalization stands at $43.33 billion, reflecting sustained investor confidence. This historical performance underscores WAT’s resilience and growth potential in the water treatment sector.

Technical Analysis

Real-time indicators across multiple timeframes

50
NEUTRAL
Momentum rank against about 1,000 stocks and ETFs for this timeframe.
Unlock full technicals
Create a free account to access more indicators and deeper timeframe data.
Institutional & Hedge Fund Ownership
25 tracked managers · $15.15B combined position · 16 adding, 9 trimming, 0 unchanged (latest 13F filings)
ManagerTrendShares Held% of Co.Position ValueFiled
BlackRock, Inc.▼ Sell8,484,9398.58%$3.18B2026-08-07
Vanguard Group Inc▼ Sell7,469,9367.55%$2.84B2026-01-29
Invesco Ltd.▲ Buy3,494,2673.53%$1.31B2026-08-14
Geode Capital Management, LLC▼ Sell2,636,1462.66%$984.75M2026-08-12
AllianceBernstein L.P.▲ Buy2,694,5902.72%$802.45M2026-08-14
JPMorgan Chase & Co▲ Buy2,158,3912.18%$796.17M2026-08-12
Viking Global Investors LP▲ Buy1,662,1401.68%$623.37M2026-08-14
Wellington Management Group LLP▲ Buy1,373,1501.39%$514.99M2026-08-14
Janus Henderson Group plc▲ Buy1,638,7721.66%$488.03M2026-05-18
Morgan Stanley▼ Sell1,097,3021.11%$411.53M2026-08-13
Northern Trust Corp▼ Sell1,032,7261.04%$387.31M2026-08-13
D. E. Shaw & Co., Inc.▼ Sell948,6390.96%$355.78M2026-08-14
FMR LLC (Fidelity)▲ Buy924,7420.93%$346.82M2026-08-13
Millennium Management LLC▲ Buy894,6600.90%$335.53M2026-08-14
Bank of America Corp▼ Sell839,5920.85%$314.88M2026-08-14
Neuberger Berman Group LLC▲ Buy638,7860.65%$239.37M2026-08-13
Goldman Sachs Group Inc▲ Buy584,2540.59%$219.12M2026-08-14
Marshall Wace, LLP▲ Buy581,3320.59%$218.02M2026-08-13
Artisan Partners Limited Partnership▲ Buy560,7530.57%$210.30M2026-08-13
Point72 Asset Management, L.P.▲ Buy444,2250.45%$166.60M2026-08-14
Capital Research Global Investors▲ New358,1980.36%$134.34M2026-08-12
Citigroup Inc▲ Buy213,2270.22%$79.97M2026-08-03
Norges Bank▼ Sell188,3340.19%$70.63M2026-08-12
Wells Fargo & Company▼ Sell168,4980.17%$63.19M2026-08-14
Adage Capital Partners GP, L.L.C.▲ Buy144,5560.15%$54.21M2026-08-14
Q2 2026 flow:5.42M sh bought ($1.99B)833.5K sh sold ($312.58M)net +4.59M sh (+$1.67B)
Congressional Trading Activity
20 disclosed trades · ~$144.0K est. traded value · 11 buys, 7 sells
MemberChamberStateTypeAmountTradedFiled
Kevin HernHouseOK01▼ Sell$1K - $15K2026-08-132026-09-01
Gilbert CisnerosHouseCA31▲ Buy$1K - $15K2026-03-182026-04-07
Thomas H. KeanHouseNJ07▼ Sell$1K - $15K2026-03-102026-04-13
Thomas H. KeanHouseNJ07▼ Sell$1K - $15K2026-02-132026-03-18
Debbie DingellHouseMI06↔ Exchange$1K - $15K2026-02-102026-02-23
Kevin HernHouseOK01↔ Exchange$1K - $15K2026-02-092026-03-06
Julia LetlowHouseLA05▲ Buy$1K - $15K2025-12-082026-01-13
Gilbert CisnerosHouseCA31▲ Buy$1K - $15K2025-09-302025-10-10
Gilbert CisnerosHouseCA31▲ Buy$1K - $15K2025-08-262025-09-12
Gilbert CisnerosHouseCA31▲ Buy$1K - $15K2025-08-132025-09-12
Gilbert CisnerosHouseCA31▲ Buy$1K - $15K2025-08-122025-09-12
Lisa McClainHouseMI09▼ Sell$1K - $15K2025-07-222025-08-13
Lisa McClainHouseMI09▲ Buy$1K - $15K2025-07-162025-08-13
Rob BresnahanHousePA08▲ Buy$1K - $15K2025-05-152025-06-09
Rob BresnahanHousePA08▼ Sell$1K - $15K2025-04-082025-05-08
Rob BresnahanHousePA08▲ Buy$1K - $15K2025-02-252025-03-27
Julia LetlowHouseLA05▲ Buy$1K - $15K2024-10-232026-01-13
Tommy TubervilleSenateAL▼ Sell$1K - $15K2024-05-032026-08-05
Tommy TubervilleSenateAL▲ Buy$1K - $15K2021-03-292021-07-23
Angus KingSenate-▼ Sell$1K - $15K2019-07-232019-08-26